XMax Board Authorizes $30M Buyback Capped at $5.50/Share
XMAX sits 45% above its 52-week low of $3.03 on elevated volume (6.3× avg).
Summary
XMax authorized repurchases of up to $30 million of stock at prices below $5.50, but buying cannot start until Q3 earnings are released and a broker is engaged. The buyback runs alongside a pending request for up to $170 million in new discounted offerings tied to the Nasdaq delisting notice.
Key Events · Financing and Capital Events · XMAX
-
Board Authorizes $30M Buyback
On October 31, 2026 the Board approved repurchases of up to $30,000,000 in aggregate purchase price of common stock, limited to prices below $5.50 per share.
-
Buyback Not Yet Active
No repurchases may occur before a Commencement Date that requires the Q3 2026 earnings release, public disclosure of any material nonpublic information, and engagement of a broker-dealer; the program expires three months after commencement.
-
Conditions Amended Same Week
The Board amended the program by unanimous written consent on November 2, 2026 to revise the conditions to commencement, one day before the November 3 press release.
-
Funding From Existing Cash
XMax expects to fund repurchases from existing cash and cash equivalents; the program obligates no particular number of shares or dollar amount and may be suspended at any time.
Analysis · XMAX · Manufacturing
For a company this size, a $30 million repurchase authorization is meaningful, but it is conditional and not yet active: no shares can be bought until XMax releases Q3 results, clears any material nonpublic information, and hires a broker-dealer, and the program expires three months after that start. The $5.50 price cap sits above today's $4.40, so the authorization is usable at current levels. The real tension is that this buyback coexists with a pending shareholder request for up to $170 million in new discounted offerings to cure the September Nasdaq 5635(d) delisting notice — cash spent on buybacks is cash not available for that, and the two programs serve different purposes rather than offsetting each other.
How filings like this one have moved
In the 30 days to Nov 3, 2026, 32.3% of the 2077 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XMAX was trading at $4.40 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $260.2M. The 52-week trading range was $3.03 to $9.40. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.